BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

713 related articles for article (PubMed ID: 25482829)

  • 1. Tenascin-C: Form versus function.
    Giblin SP; Midwood KS
    Cell Adh Migr; 2015; 9(1-2):48-82. PubMed ID: 25482829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional regulation of tenascin genes.
    Chiovaro F; Chiquet-Ehrismann R; Chiquet M
    Cell Adh Migr; 2015; 9(1-2):34-47. PubMed ID: 25793574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors.
    Selinger M; Věchtová P; Tykalová H; Ošlejšková P; Rumlová M; Štěrba J; Grubhoffer L
    Comput Struct Biotechnol J; 2022; 20():2759-2777. PubMed ID: 35685361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tenascin-C and carcinoma cell invasion in oral and urinary bladder cancer.
    Berndt A; Richter P; Kosmehl H; Franz M
    Cell Adh Migr; 2015; 9(1-2):105-11. PubMed ID: 25793577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns.
    Chatterton DE; Nguyen DN; Bering SB; Sangild PT
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1730-47. PubMed ID: 23660296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tenascin-C and integrins in cancer.
    Yoshida T; Akatsuka T; Imanaka-Yoshida K
    Cell Adh Migr; 2015; 9(1-2):96-104. PubMed ID: 25793576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor-I (IGF-I) and transforming growth factor-beta (TGF-beta) modulate tenascin-C and fibrillin-1 in bullous keratopathy stromal cells in vitro.
    Kenney MC; Zorapapel N; Atilano S; Chwa M; Ljubimov A; Brown D
    Exp Eye Res; 2003 Nov; 77(5):537-46. PubMed ID: 14550395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice.
    Stamatopoulos A; Stamatopoulos T; Gamie Z; Kenanidis E; Ribeiro RDC; Rankin KS; Gerrand C; Dalgarno K; Tsiridis E
    J Bone Oncol; 2019 Jun; 16():100231. PubMed ID: 30956944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenascin-X: beyond the architectural function.
    Valcourt U; Alcaraz LB; Exposito JY; Lethias C; Bartholin L
    Cell Adh Migr; 2015; 9(1-2):154-65. PubMed ID: 25793578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Met expression in renal cell carcinoma with bone metastases.
    Silva Paiva R; Gomes I; Casimiro S; Fernandes I; Costa L
    J Bone Oncol; 2020 Dec; 25():100315. PubMed ID: 33024658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postprandial lipoproteins and the molecular regulation of vascular homeostasis.
    Botham KM; Wheeler-Jones CP
    Prog Lipid Res; 2013 Oct; 52(4):446-64. PubMed ID: 23774609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological drug and drug delivery-mediated immunotherapy.
    Xiao Q; Li X; Li Y; Wu Z; Xu C; Chen Z; He W
    Acta Pharm Sin B; 2021 Apr; 11(4):941-960. PubMed ID: 33996408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment.
    Zhang M; Hu W; Cai C; Wu Y; Li J; Dong S
    Mater Today Bio; 2022 Mar; 14():100223. PubMed ID: 35243298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Good or not good: Role of miR-18a in cancer biology.
    Kolenda T; Guglas K; Kopczyńska M; Sobocińska J; Teresiak A; Bliźniak R; Lamperska K
    Rep Pract Oncol Radiother; 2020; 25(5):808-819. PubMed ID: 32884453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGF-Like domain of tenascin-C is proapoptotic for cultured smooth muscle cells.
    Wallner K; Li C; Shah PK; Wu KJ; Schwartz SM; Sharifi BG
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1416-21. PubMed ID: 15178565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of an environmental niche for neural stem cell development by the extracellular matrix molecule tenascin C.
    Garcion E; Halilagic A; Faissner A; ffrench-Constant C
    Development; 2004 Jul; 131(14):3423-32. PubMed ID: 15226258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenascin-Y: a protein of novel domain structure is secreted by differentiated fibroblasts of muscle connective tissue.
    Hagios C; Koch M; Spring J; Chiquet M; Chiquet-Ehrismann R
    J Cell Biol; 1996 Sep; 134(6):1499-512. PubMed ID: 8830777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fibrinogen-like globe of tenascin-C mediates its interactions with neurocan and phosphacan/protein-tyrosine phosphatase-zeta/beta.
    Milev P; Fischer D; Häring M; Schulthess T; Margolis RK; Chiquet-Ehrismann R; Margolis RU
    J Biol Chem; 1997 Jun; 272(24):15501-9. PubMed ID: 9182584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.